GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q1 2024 GSK plc Earnings Call Transcript

May 01, 2024 / NTS GMT
Release Date Price: $42.57 (+2.73%)
Nick Stone

Hello, everyone. Welcome to today's call and webcast. The presentation was sent to our distribution list by e-mail, and you can find this on gsk.com.

Please turn to Slide 2. This is the usual safe harbor statement. We'll comment on our performance using constant exchange rates, or CR unless stated otherwise. As a reminder, adjusted results are now referred to as core like many European pharmaceutical peers.

Please turn to Slide 3. Today's call will last approximately 1 hour with the presentation taking around 25 minutes and the remaining time for your questions. Today, our speakers are Emma Walmsley, Luke Miels, Deborah Waterhouse, and Julie Brown with Tony Wood and David Redfern joining for Q&A. Please ask 1 to 2 questions so that everyone has the chance to participate.

Turning to Slide 4. I will now hand the call over to Emma.

Emma Natasha Walmsley
GSK plc - CEO & Director

Thanks, Nick, and welcome to everybody joining us today. I'm delighted to be presenting to you all with another set of excellent quarterly results for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot